Properties and applications of antimicrobial proteins and peptides from milk and eggs

Bioactive Food Proteins and Peptides: Applications in Human Health

Volumn , Issue , 2011, Pages 49-96

  Korhonen, Hannu J ^a   Rokka, Susanna ^a  

^a FINNISH FOREST RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALS; PEPTIDES;

ANTIMICROBIAL PROTEINS; BIOACTIVE COMPOUNDS; BIOPRESERVATION; MICROBIAL INFECTIONS; NATURAL SOURCES; NUTRACEUTICALS; PHARMACEUTICAL INDUSTRY; PHARMACEUTICAL PREPARATIONS;

MICROORGANISMS;

EID: 84926247380     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (241)

1. Abd El-Salam, M.H., El-Shibini, S., and Buchheim, W. 1996. Characteristics and potential uses of the casein macropeptide. Int. Dairy J. 6: 327-341.
2. Abdou, A.M., Higashiguchi, S., Aboueleinin, A.M., Kim, M., and Ibrahim, H.R. 2007. Antimicrobial peptides derived from hen egg lysozyme with inhibitory effect against bacillus species. Food Control 18(2): 173-178.
3. Akita, E.M. and Nakai, S. 1992. Immunoglobulins from egg yolk: Isolation and purification. J. Food Sci. 57: 629-634.
4. Almaas, H., Holm, H., Langsrud, T., Flengsrud, R., and Vegarud, G.E. 2006. In vitro studies of the digestion of caprine whey proteins by human gastric and duode­nal juice and the effects on selected microorganisms. Brit. J. Nutr. 96(3): 562-569.
5. Andrews, S.C., Robinson, A.K., and Rodriguez-Quinones, F. 2003. Bacterial iron homeostasis. FEMS Microbiology Rev. 27(2-3): 215-237.
6. Anon. 2005. Benefits and potential risks of the lactoperoxidase system of raw milk preservation. Report of an FAO/WHO technical meeting. FAO Headquarters, Rome, 28 November-2 December.
7. Appel, M.J., van Veen, H.A., Vietsch, H., Salaheddine, M., Nuijens, J.H., Ziere, B., and de Loos, F. 2006. Sub-chronic (13-week) oral toxicity study in rats with recom­binant human lactoferrin produced in the milk of transgenic cows. Food Chem. Toxicol. 44(7): 964-973.
8. Appelmelk, B.J., An, Y.Q., Geerts, M., Thijs, B.G., de Boer, H.A., MacLaren, D.M., de Graaff, J., and Nuijens, J.H. 1994. Lactoferrin is a lipid A-binding protein. Infect, Immunity 62(6): 2628-2632.
9. Arnold, D., Di Biase, A.M., Marchetti, M., Pietrantoni, A., Valenti, P., Seganti, L., and Superti, F. 2002. Antiadenovirus activity of milk proteins: Lactoferrin prevents viral infection. Antiviral Res. 53(2): 153-158.
10. Ashraf, H., Mahalanabis, D., Mitra, A.K., Tzipori, S., and Fuchs, G.J. 2001. Hyperimmune bovine colostrum in the treatment of shigellosis in children: A double-blind, randomized, controlled trial. Acta Paediatrica 90(12): 1373-1378.
11. Attallah, A.M., Abbas, A.T., Ismail, H., Abdel-Raouf, M., and El-Dosoky, I. 2009. Efficacy of passive immunization with IgY antibodies to a 58-kDa H. pylori antigen on severe gastritis in BALB/c mouse model. J. Immunoassay Immunochem. 30(4): 359-377.
12. Baker, E.N., Baker, H.M., and Kidd, R.D. 2002. Lactoferrin and transferrin: Functional variations on a common structural framework. Biochem. Cell Biol. 80(1): 27-34.
13. Bellamy, W., Takase, M., Wakabayashi, H., Kawase, K., and Tomita, M. 1992. Antibacterial spectrum of lactoferricinB, a potent bacterial peptide from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73: 472-479.
14. Bojsen, A., Buesa, J., Montava, R., Kvistgaard, A.S., Kongsbak, M.B., Petersen, T.E., Heegaard, C.W., and Rasmussen, J.T. 2007. Inhibitory activities of bovine mac­romolecular whey proteins on rotavirus infections in vitro and in vivo. J. Dairy Sci. 90(1): 66-74.
15. Bölke, E., Jehle, P.M., Hausmann, F., Daubler, A., Wiedeck, H., Steinbach, G., Storck, M., and Orth, K. 2002. Preoperative oral application of immunoglobulin-enriched colostrum milk and mediator response during abdominal surgery. Shock 17(1): 9-12.
16. Bölke, E., Orth, K., Jehle, P.M., Schwarz, A., Steinbach, G., Schleich, S., Ulmer, C., Storck, M., and Hannekum, A. 2002. Enteral application of an immunoglobulin-enriched colostrum milk preparation for reducing endotoxin translocation and acute phase response in patients undergoing coronary bypass surgery-A randomized placebo-controlled pilot trial. Wiener Klinische Wochenschrift 114(21-22): 923-928.
17. Boots, J.-W. and Floris, R. 2006. Lactoperoxidase: From catalytic mechanism to practical applications. Int. Dairy J. 16: 1272-1276.
18. Born, J. and Bhakdi, S. 1986. Does complement kill E. coli by producing transmural pores? Immunology 59(1): 139-145.
19. Bostwick, E.F., Steijns, J., and Braun, S. 2000. Lactoglobulins. In: Natural Food Antimicrobial Systems (A.S. Naidu, Ed.), Boca Raton, FL: CRC Press, 133-158.
20. Braun, V. and Killmann, H. 1999. Bacterial solutions to the iron-supply problem. Trends in Biochem. Sci. 24(3): 104-109.
21. Brinkworth, G.D. and Buckley, J.D. 2003. Concentrated bovine colostrum protein sup­plementation reduces the incidence of self-reported symptoms of upper respira­tory tract infection in adult males. Euro. J. Nutr. 42(4): 228-232.
22. Brody, E.P. 2000. Biological activities of bovine glycomacropeptide. Brit. J. Nutr. 84: S39-S46.
23. Brown, C.A., Wang, B., and Oh, J.H. 2008. Antimicrobial activity of lactoferrin against foodborne pathogenic bacteria incorporated into edible chitosan film. J. Food Protect. 71(2): 319-324.
24. Brück, W.M., Kelleher, S.L., Gibson, G.R., Nielsen, K.E., Chatterton, D.E., and Lönnerdal, B. 2003. rRNA probes used to quantify the effects of glycomacropeptide and α-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J. Pediatr. Gastroent. Nutr. 37: 273-280.
25. Brück, W.M., Redgrave, M., Tuohy, K.M., Lönnerdal, B., Graverholt, G., Hernell, O., and Gibson, G.R. 2006. Effects of bovine alpha-lactalbumin and casein glyco-macropeptide-enriched infant formulae on faecal microbiota in healthy term infants. J. Pediatr. Gastroent. Nutr. 43(5): 673-679.
26. Butler, J.E. 1998. Immunoglobulin diversity, B-cell and antibody repertoire development in large farm animals. Revue Scientifique et Technique, 17(1): 43-70.
27. Campbell, B. and Petersen, W.E. 1963. Immune milk-a historical survey. Dairy Sc. Abstr. 25: 345-358.
28. Carlander, D., Kollberg, H., and Larsson, A. 2002. Retention of specific yolk IgY in the human oral cavity. BioDrugs: Clin. Immunotherapeut. Biopharmaceut. Gene Therapy 16(6): 433-437.
29. Casswall, T.H., Nilsson, H.O., Björck, L., Sjöstedt, S., Xu, L., Nord, C.K., Boren, T., Wadström, T., and Hammarström, L. 2002. Bovine anti-helicobacter pylori antibodies for oral immunotherapy. Scand. J. Gastroenter. 37(12): 1380-1385.
30. Casswall, T.H., Sarker, S.A., Albert, M.J., Fuchs, G.J., Bergstrom, M., Björck, L., and Hammarström, L. 1998. Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colos­trum. Aliment. Pharmacol. Therapeut. 12(6): 563-568.
31. Casswall, T.H., Sarker, S.A., Faruque, S.M., Weintraub, A, Albert, M.J., Fuchs, G.J., Alam, N.H. et al. 2000. Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: A double-blind, placebo-controlled, clinical trial. Scand. J. Gastroent. 35(7): 711-718.
32. Cerven, D., DeGeorge, G., and Bethell, D. 2008. 28-Day repeated dose oral toxicity of recombinant human apo-lactoferrin or recombinant human lysozyme in rats. Reg. Toxicol. Pharmacol. 51(2): 162-167.
33. Chalghoumi, R., Beckers, Y., Portetelle, D., and Théwis, A. 2009a. Hen egg yolk anti­bodies (IgY), production and use for passive immunization against bacterial enteric infections in chicken: A review. Biotechnol. Agron. Soc. Environ. 13(2): 295-308.
34. Chalghoumi, R., Marcq, C., Thewis, A., Portetelle, D., and Beckers, Y. 2009b. Effects of feed supplementation with specific hen egg yolk antibody (immunoglobin Y) on Salmonella species cecal colonization and growth performances of chal­lenged broiler chickens. Poult. Sci. 88(10): 2081-2092.
35. Chan, J.C.K. and Li-Chan, E.C.Y. 2006. Antimicrobial peptides. In Nutraceutical Proteins and Peptides in Health and Disease (Y. Mine and F. Shahidi, Eds.), Boca Raton, FL: Taylor & Francis, pp. 99-136.
36. Clare, D.A., Catignani, G.L., and Swaisgood, H.E. 2003. Biodefense properties of milk: The role of antimicrobial proteins and peptides. Curr. Pharmaceut. Des. 9: 1239-1255.
37. Conesa, C., Sánchez, L., Rota, C., Pérez, M.-D., Calvo, M., Farnaud, S., and Evans, R.W. 2008. Isolation of lactoferrin from milk of different species: Calorimetric and antimicrobial studies. Compar. Biochem. Physiol. B, 150: 131-139.
38. Costantino, D. and Guaraldi, C. 2008. Preliminary evaluation of a vaginal cream containing lactoferrin in the treatment of vulvovaginal candidosis. Minerva Ginecologica 60(2): 121-125.
39. Davidson, G.P., Whyte, P.B., Daniels, E., Franklin, K., Nunan, H., McCloud, P.I., Moore, A.G., and Moore, D.J. 1989. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 2(8665): 709-712.
40. Diarra, M.S., Petitclerc, D., Deschênes, É., Lessard, N., Grondin, G., Talbot, B.G., and Lacasse, P. 2003. Lactoferrin against staphylococcus aureus mastitis: Lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary epithelial cells colonisation by staphylococcus aureus. Veterinary Immunol. Immunopathol. 95(1-2): 33-42.
41. Diarra, M.S., Petitclerc, D., and Lacasse, P. 2002. Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci. 85(5): 1141-1149.
42. Earnest, C.P., Jordan, A.N., Safir, M., Weaver, E., and Church, T.S. 2005. Cholesterol-lowering effects of bovine serum immunoglobulin in participants with mild hypercholesterolemia. Amer. J. Clin. Nutr. 81(4): 792-798.
43. Ebina, T., Sato, A., Umezu, K., Ishida, N., Ohyama, S., Oizumi, A., Aikawa, K., Katagiri, S., Katsushima, N., and Imai, A. 1985. Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody. Med. Microbiol. Immunol. 174(4): 177-185.
44. Ehrlich, P. 1892. Über immunität durch verebung und zeugung. Zeitschrift für Hygiene und Infektionskrankheiten 12: 183-203.
45. Elfstrand, L., Lindmark-Månsson, H., Paulsson, M., Nyberg, L., and Åkesson, B. 2002. Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing. Int. Dairy J. 12(11): 879-887.
46. Ellison, R.T. and Giehl T.J. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88(4): 1080-1091.
47. Farkye, N.Y. 2002a. Enzymes indigenous to milk-Other enzymes. In Encyclopedia of Dairy Sciences (H. Roginski, J.F. Fuquay, and P.F. Fox, Eds.), London: Academic Press/Elsevier Science, pp. 943-948.
48. Farkye, N.Y. 2002b. Enzymes indigenous to milk-Xanthine oxidase. In Encyclopedia of Dairy Sciences (H. Roginski, J.F. Fuquay, and P.F. Fox, Eds.), London: Academic Press/Elsevier Science, pp. 941-942.
49. Fernaud, S. and Evans, R.W. 2003. Lactoferrin-amultifunctional protein with antimi­crobial properties. Molec. Immunol. 40: 395-405.
50. FitzGerald, R.J. and Murray, B.A. 2006. Bioactive peptides and lactic fermentations. Int. J. Dairy Tech. 59: 118-125.
51. Fleming, A. 1922. On a remarkable bacteriolytic element found in tissues and secre­tions. Proc. Roy. Soc. B93:306.
52. Floren, C.H., Chinenye, S., Elfstrand, L., Hagman, C., and Ihse, I. 2006. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand. J. Gastroent. 41(6): 682-686.
53. Floris, R., Recio, I., Berkhout, B., and Visser, S. 2003. Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr. Pharmaceut. Des. 9: 1257-1275.
54. Fukumoto, L.R., Li-Chan, E., Kwan, L., and Nakai, S. 1994. Isolation of immunoglobu­lins from cheese whey using ultrafiltration and immobilized metal affinity chro­matography. Food Res. Int. 27(4): 335-348.
55. Funatogawa, K., Ide, T., Kirikae, F., Saruta, K., Nakano, M., and Kirikae, T. 2002. Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice. Microbiol. Immunol. 46(11): 761-766.
56. Gerson, C., Sabater, J., Scuri, M., Torbati, A., Coffey, R., and Abraham, J. et al. 2000. The lactoperoxidase system functions in bacterial clearance of airways. Amer. J. Respir. Cell Molec. Biol. 22: 665-671.
57. Giansanti, F., Massucci, M.T., Giardi, M.F., Nozza, F., Pulsinelli, E., Nicolini, C. et al. 2005. Antiviral activity of ovotransferrin derived peptides. Biochem. Biophys. Res. Commun. 331(1): 69-73.
58. Gobbetti, M., Minervini, F., and Rizzello, C.G. 2004. Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int. J. Dairy Technol. 57: 172-188.
59. Gobbetti, M., Minervini, F., and Rizzello, C.G. 2007. Bioactive peptides in dairy products. In Handbook of Food Products Manufacturing (Y.H. Hui, Ed.), Hoboken, NJ: John Wiley & Sons, pp. 489-517.
60. Gomez, H.F., Ochoa, T.J., Carlin, L.G., and Cleary, T.G. 2003. Human lactoferrin impairs virulence of Shigella flexneri. J. Infect. Diseases 187(1): 87-95.
61. Gong, D., Wilson, P., Bain, M., McDade, K., Kalina, J., Herve-Grepinet, V. et al. 2010. Gallin; An antimicrobial peptide member of a new avian defensin family, the ovodefensins, has been subject to recent gene duplication. BMC Immunol. 11(1): 12.
62. Gurtler, M., Methner, U., Kobilke, H., and Fehlhaber, K. 2004. Effect of orally administered egg yolk antibodies on salmonella enteritidis contamination of hen‘s eggs. J. Veterinary Med. B, Infect. Diseases Veterinary Public Health 51(3): 129-134.
63. Hammarström, L. and Weiner, C.K. 2008. Targeted antibodies in dairy-based products. Adv. Exper. Med. Biol. 606: 321-343.
64. Hanssen, F.W. 1924. The bactericidal property of milk. Brit. J. Exper. Pathol. 5:271.
65. Hatta, H., Tsuda, K., Akachi, S., Kim, M., Yamamoto, T., and Ebina, T. 1993. Oral passive immunization effect of anti-human rotavirus IgY and its behavior against proteolytic enzymes. Biosci. Biotechnol. Biochem. 57(7): 1077-1081.
66. Haukland, H.H., Ulvatne, H., Sandvik, K., and Vorland, L.H. 2001. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett. 508: 389-93.
67. Hiraga, C., Kodama, Y., Sugiyama, T., and Ichikawa, Y. 1990. Prevention of human rotavirus infection with chicken egg yolk immunoglobulins containing rotavirus antibody in cat. J. Jpn. Assoc. Infect. Diseases 64(1): 118-123.
68. Hoerr, R.A. and Bostwick, E.F 2002. Commercializing colostrum based products: A case study of Galagen Inc. Int. Dairy Fed. Bull. 375: 33-46.
69. Horie, K., Horie, N., Abdou, A.M., Yang, J.O., Yun, S.S., Chun, H.N., Park, C.K., Kim, M., and Hatta, H. 2004. Suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on helicobacter pylori in humans. J. Dairy Sci. 87(12): 4073-4079.
70. Huang, X.H., Chen, L., Gao, W., Zhang, W., Chen, S.J., Xu, L.B., and Zhang, S.Q. 2008. Specific IgG activity of bovine immune milk against diarrhea bacteria and its protective effects on pathogen-infected intestinal damages. Vaccine 26(47): 5973-5980.
71. Ibrahim, H.R., Inazaki, D., Abdou, A., Aoki, T., and Kim, M. 2005. Processing of lysozyme at distinct loops by pepsin: A novel action for generating multiple antimicrobial peptide motifs in the newborn stomach. Biochimica et Biophysica Acta 1726(1): 102-114.
72. Ibrahim, H.R., Sugimoto, Y., and Aoki, T. 2000. Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism. Biochimica et Biophysica Acta 1523(2-3): 196-205.
73. Ibrahim, H.R., Thomas, U., and Pellegrini, A. 2001. A helix-loop peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. J. Biol. Chem. 276: 43767-43774.
74. Ikemori, Y., Kuroki, M., Peralta, R.C., Yokoyama, H., and Kodama, Y. 1992. Protection of neonatal calves against fatal enteric colibacillosis by administration of egg yolk powder from hens immunized with K99-piliated enterotoxigenic escherichia coli. Amer. J. Veterinary Res. 53(11): 2005-2008.
75. Ikemori, Y., Ohta, M., Umeda, K., Icatlo, F.C., Kuroki, M., Yokoyama, H., and Kodama, Y. 1997. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder. Veterinary Microbiol. 58(2-4): 105-111.
76. Isamida, T., Tanaka, T., Omata, Y., Yamauchi, K., Shimazaki, K., and Saito, A. 1998. Protective effect of lactoferricin against Toxoplasma gondii infection in mice. J. Veterinary Med. Sci. 60:241-244.
77. Jenssen, H. and R.E.W. Hancock. 2009. Antimicrobial properties of lactoferrin. Biochimie 91:19-29.
78. Johnson, E.A. 1994. Egg white lysozyme as a preservative for use in foods. In Egg Uses and Processing Technologies: New Developments (J.S. Sim and S. Nakai, Eds.), Oxon: CABI, pp. 177-191
79. Kamau, S.M., Cheison, S.C., Chen, W., Liu, X.-M., and Lu, R.-R. 2010. Alpha-Lactalbumin: Its production technologies and bioactive peptides. Comp. Rev. Food Sci. Food Safety 9:197-212.
80. Kokko, H., Kuronen, I., and Kärenlampi, S. 1998. Rapid production of antibodies in chicken and isolation from eggs. In Cell Biology: A Laboratory Handbook, 2nd edition, Volume 2 (J. Celis, Ed.), San Diego: Academic Press, 410-417.
81. Kollberg, H., Carlander, D., Olesen, H., Wejaker, P.E., Johannesson, M., and Larsson A. 2003. Oral administration of specific yolk antibodies (IgY) may prevent pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study. Pediatr. Pulmonol. 35(6): 433-440.
82. Komine, Y., Kuroishi, T., Kobayashi, J., Aso, H., Obara, Y., Kumagai, K. et al. 2006. Inflammatory effect of cleaved bovine lactoferrin by elastase on staphylococcal mastitis. J. Veterinary Med. Sci. 68(7): 715-723.
83. Korhonen, H. 2002. Technology options for new nutritional concepts. Int. J. Dairy Technol. 55: 79-88.
84. Korhonen, H. 2009a. Bioactive milk peptides: from science to applications. J. Funct. Foods 1(2): 177-187.
85. Korhonen, H. 2009b. Bioactive components in bovine milk. In Bioactive Components in Milk and Dairy Products (Y. Park, Ed.), Ames, IA: Wiley-Blackwell, pp. 15-42.
86. Korhonen, H. 2009c. Bioactive whey proteins and peptides: Functional solutions for health-promotion. Nutrafoods 8(4): 9-22.
87. Korhonen, H. and P. Marnila. 2006. Bovine milk antibodies for protection against microbial human diseases. In Nutraceutical Proteins and Peptides in Health and Disease (Y. Mine, and F. Shahidi, Eds.), Boca Raton, FL: Taylor & Francis, pp. 137-159.
88. Korhonen, H. and Marnila, P. 2009. Bovine milk immunoglobulins against microbial human diseases. In Dairy-Derived Ingredients: Food and Nutraceutical Uses (M. Corredig, Ed.), Oxford, UK: Woodhead, pp. 269-289.
89. Korhonen, H., Marnila, P., and Gill, H.S. 2000a. Bovine milk antibodies for health. British J. Nutr. 84 Suppl 1(Nov): S135-S146.
90. Korhonen, H., Marnila, P., and Gill, H.S. 2000b. Milk immunoglobulins and complement factors. Brit. J. Nutr. 84 Suppl 1(Nov): S75-S80.
91. Korhonen, H. and Pihlanto A. 2006. Bioactive peptides: Production and functionality. Int. Dairy J. 16(9): 945-960.
92. Korhonen, H. and Pihlanto, A. 2007a. Bioactive peptides from food proteins. In Handbook of Food Products Manufacturing: Health, Meat, Milk, Poultry, Seafood, and Vegetables (Y.H. Hui, Ed.), Hoboken, NJ: John Wiley & Sons, pp. 5-38.
93. Korhonen, H. and Pihlanto, A. 2007b. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr. Pharmaceuti. Des. 13(8): 829-843.
94. Korhonen, H., Syväoja, E.L., Ahola-Luttila, H., Sivelä, S., Kopola, S., Husu, J., and Kosunen, T.U. 1995. Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J. Appl. Bacteriol. 78(6): 655-662.
95. Kovacs-Nolan, J., Mine, Y., and Hatta, H. 2006. Avian immunoglobulin Y and its application in human health and disease. In NutraceuticalProteins and Peptides in Health and Disease (Y. Mine and F. Shahidi, Eds.), Boca Raton, FL: Taylor & Francis, pp. 161-189.
96. Kovacs-Nolan, J., Phillips, M., and Mine, Y. 2005. Advances in the value of eggs and egg components for human health. J. Agricult. Food Chem. 53(22): 8421-8431.
97. Kulozik, U. 2009. Novel approaches for the separation of dairy components and manufacture of dairy ingredients. In Dairy-Derived Ingredients: Food and Nutraceutical Uses (M. Corredig, Ed.), Oxford, UK: Woodhead, pp. 3-23.
98. Kuroiwa, Y., Kasinathan, P., Sathiyaseelan, T., Jiao, J.A., Matsushita, H., Sathiyaseelan, J. et al. 2009. Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nature Biotechnol. 27, 173-181.
99. Kussendrager, K.D. and van Hooijdonk, A.C.M. 2000. Lactoperoxidase: Physico-chemical properties, occurrence, mechanism of action and applications. Brit. J. Nutr. 84(Suppl 1): 19-25.
100. Kweon, C.H., Kwon, B.J., Woo, S.R., Kim, J.M., Woo, G.H., Son, D.H., Hur, W., and Lee, Y.S. 2000. Immunoprophylactic effect of chicken egg yolk immunoglobulin (Ig Y) against porcine epidemic diarrhea virus (PEDV) in piglets. J. Veterinary Med. Sci. 62(9): 961-964.
101. Lacasse, P., Lauzon, K., Diarra, M.S., and Petitclerc, D. 2008. Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens. J. Anim. Sci. 86(13 Suppl): 66-71.
102. Lahov, E. and Regelson, W. 1996. Antibacterial and immunostimulating casein-derived substances from milk: Casecidin, isracidin peptides. Food Chem. Toxicol. 34:131-145.
103. Lee, S., Mine, B.Y., and Stevenson, R.M.W. 2000. Effects of hen egg yolk immunoglobulin in passive protection of rainbow trout against Yersinia ruckeri. J. Agric. Food Chem. 48(1): 110-115.
104. Lee, S.H., Lillehoj, H.S., Park, D.W., Jang, S.I., Morales, A., Garcia, D., Lucio, E. et al. 2009. Induction of passive immunity in broiler chickens against Eimeria acervulina by hyperimmune egg yolk immunoglobulin Y. Poultry Sci. 88(3): 562-566.
105. Lee-Huang, S., Huang, P.L., Sun, Y., Huang, P.L., Kung, H.F., Blithe, D.L., and Chen, H.C. 1999. Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. Proc. Nat.Acad. Sci. U.S.A. 96:2678-2681.
106. Leitch, E.C. and Willcox, M.D. 1998. Synergic antistaphylococcal properties of lactoferrin and lysozyme. J. Med. Microbiol. 47(9): 837-842.
107. Lilius, E.-M. and Marnila, P. 2001. The role of colostral antibodies in prevention of microbial infections. Curr. Opin. Infect. Diseases 14: 295-300.
108. Lizzi, A.R., Carnicelli, V., Clarkson, M.M., Di Giulio, A., and Oratore, A. 2009. Lactoferrin derived peptides: Mechanisms of action and their perspectives as antimicrobial and antitumoral agents. Mini Rev. Med. Chem. 9: 687-695.
109. Loimaranta, V., Carlen, A., Olsson, J., Tenovuo, J., Syväoja, E.L., and Korhonen, H. 1998a. Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci. J. Dairy Res. 65(4): 599-607.
110. Loimaranta, V., Laine, M., Soderling, E., Vasara, E., Rokka, S., Marnila, P., Korhonen, H. et al. 1999a. Effects of bovine immune and non-immune whey preparations on the composition and pH response of human dental plaque. Euro. J. Oral Sci. 107(4): 244-250.
111. Loimaranta, V., Nuutila, J., Marnila, P., Tenovuo, J., Korhonen, H., and Lilius, E.M. 1999b. Colostral proteins from cows immunised with Streptococcus mutans/S. sobrinus support the phagocytosis and killing of mutans streptococci by human leucocytes. J. Med. Microbiol. 48(10): 917-926.
112. Loimaranta, V., Tenovuo, J., and Korhonen, H. (1998b). Combined inhibitory effect of bovine immune whey and peroxidase-generated hypothiocyanite against glucose uptake by Streptococcus mutans. Oral Microbiol. Immunol. 13(6), 378-381.
113. Loimaranta, V., Tenovuo, J., Virtanen, S., Marnila, P., Syväoja, E.-L., Tupasela, T., and Korhonen, H. 1997. Generation of bovine immune colostrum against Streptococcus mutans and Streptococcus sobrinus and its effect on glucose uptake and extracellular polysaccharide formation by mutans streptococci. Vaccine 15(11): 1261-1268.
114. Longhi, C., Conte, M.P., Ranaldi, S., Penta, M., Valenti, P. Tinari, A. et al. 2005. Apoptotic death of Listeria monocytogenes-infected human macrophages induced by lactoferricin B, a bovine lactoferrin-derived peptide. Int. J. Immunopath. Pharmacol. 18(2): 317-325.
115. Lönnerdal, B. 2003. Lactoferrin. In Advanced Dairy Chemistry, Vol. 1, Proteins, 3rd edition (P.F. Fox and P.L.H. McSweeney, Eds.), New York: Kluwer Academic/Plenum, pp. 449-466.
116. Lönnerdal, B. and Bryant, A. 2006. Absorption of iron from recombinant human lactoferrin in young US women. Amer. J. Clin. Nutr. 83(2): 305-309.
117. Lönnerdal, B. and Iyer, S. 1995. Lactoferrin: A general review. Haematologica 80: 252-267.
118. López-Expósito, I., Quiros, A., Amigo, L., and Recio, I. 2007. Casein hydrolysates as a source of antimicrobial, antioxydant and antihypertensive peptides. Lait 87: 241-249.
119. López-Expósito, I. and Recio, I. 2006. Antibacterial activity of peptides and folding variants from milk proteins. Int. Dairy J.16: 1294-1305.
120. López-Soto, F., León-Sicairos, N., Nazmi, K., Bolscher, J.G., and de la Garza, M. 2010. Microbicidal effect of the lactoferrin peptides Lactoferricin 17-30, Lactoferrampin 265-284, and Lactoferrin chimera on the parasite Entamoeba histolytica. Biometals. 23(3): 563-568.
121. Losso, J.N., Nakai, S., and Charter, E.A. 2000. Lysozyme. In Natural Food Antimicrobial Systems (A.S. Naidu, Ed.), New York: CRC Press, pp. 185-210.
122. Mahdavi, A.H., Rahmani, H.R., Nili, N., Samie, A.H., Soleimanian-Zad, S., and Jahanian, R. 2010. Effects of dietary egg yolk antibody powder on growth performance, intestinal Escherichia coli colonization, and immunocompetence of challenged broiler chicks. Poultry Sci. 89(3): 484-494.
123. Makino, Y. and Nishimura, S. 1992. High-performance liquid chromatographic separation of human apolactoferrin and monoferric and diferric lactoferrins. J. Chrom. 579(2): 346-349.
124. Malkoski, M., Dashper, S.G., O’Brien-Simpson, N.M., Talbo, G.H., Macris, M., Cross, K.J., and Reynolds, E.C. 2001. Kappacin, a novel antibacterial peptide from bovine milk. Antimicrob. Agents Chemother. 45(8): 2309-2315.
125. Manso, M.A. and López-Fandino, R. 2004. Κ-Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses. Food Rev. Int. 20: 329-355.
126. Markiewski, M.M. and Lambris, J.D. 2007. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Amer. J. Pathol. 171(3): 715-727.
127. Marnila, P. and Korhonen, H. 2002. Immunoglobulins. In Encyclopedia of Dairy Sciences (H. Roginski, J.W. Fuquay, and P.F. Fox, Eds.), London: Academic Press, pp. 1950-1956.
128. Marnila, P. and Korhonen, H.J. 2009. Lactoferrin for human health. In Dairy-Derived Ingredients: Food and Nutraceutical Uses (M. Corredig, Ed.), Oxford, UK: Woodhead, pp. 290-307.
129. Marnila, P., Rokka, S., Rehnberg-Laiho, L., Kärkkäinen, P., Kosunen, T.U., Rautelin, H. et al. 2003. Prevention and suppression of helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 8(3): 192-201.
130. Masci, J.R. 2000. Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme. AIDS 14(15): 2403-2404.
131. Mathew, A.G., Rattanatabtimtong, S., Nyachoti, C.M., and Fang, L. 2009. Effects of in-feed egg yolk antibodies on Salmonella shedding, bacterial antibiotic resistance, and health of pigs. J. Food Protect. 72(2): 267-273.
132. Matin, M.A. and Otani, H. 2002. Cytotoxic and antibacterial activities of chemically synthesized κ-casecidin and its partial peptide fragments. J. Dairy Res. 69: 329-334.
133. Mattila, E., Anttila, V.J., Broas, M., Marttila, H., Poukka, P., Kuusisto, K. et al. 2008. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial’ Scand. J. Infect. Diseases 40(9): 702-708.
134. McCann, K.B., Lee, A., Wan, J., Roginski, H., and Coventry, M.J. 2003. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J. Appl. Microbiol. 95(5): 1026-1033.
135. McCann, K.B., Shiell, B.J., Michalski, W.P., Lee, A., Wan, J., Roginski, H. et al. 2005. Isolation and characterisation of antibacterial peptides derived from the f(164-207) region of bovine αs2-casein. Int. Dairy J. 15: 133-143.
136. McCann, K.B., Shiell, B.J., Michalski, W.P., Lee, A., Wan, J., Roginski, H. et al. 2006. Isolation and characterisation of a novel antibacterial peptide from bovine αs1-casein. Int. Dairy J. 16: 316-323.
137. Mehra, R., Marnila, P., and Korhonen, H. 2006. Milk immunoglobulins for health promotion. Int. Dairy J. 16(11): 1262-1271.
138. Min, S., Harris, L.J., and Krochta, J.M. 2006. Inhibition of Salmonella enterica and Escherichia coli O157:H7 on roasted turkey by edible whey protein coatings incorporating the lactoperoxidase system. J. Food Protect. 69: 784-793.
139. Mine, Y. and Kovacs-Nolan, J. 2002. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: A review. J. Med. Food 5(3): 159-169.
140. Mine, Y. and Kovacs-Nolan, J. 2004. Biologically active hen egg components in human health and disease. J. Poult. Sci. 41: 1-29.
141. Mine, Y., Ma, F., and Lauriau, S. 2004. Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. J. Agric. Food Chem. 52(5): 1088-1094.
142. Mitoma, M., Oho, T., Michibata, N., Okano, K., Nakano, Y., Fukuyama, M., and Koga, T. 2002. Passive immunization with bovine milk containing antibodies to a cell surface protein antigen-glucosyltransferase fusion protein protects rats against dental caries. Infect. Immun. 70(5): 2721-2724.
143. Mor, A. 2003. Introduction. Peptides 24: 1645.
144. Näse, L., Hatakka, K., Savilahti, E., Saxelin, M., Ponka, A., Poussa, T., Korpela, R., and Meurman, J.H. 2001. Effect of long-term consumption of a probiotic bacterium, lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 35(6): 412-420.
145. Nibbering, P.H., Ravensbergen, E., Welling, M.M., van Berkel, L.A., van Berkel, P.H., Pauwels, E.K., and Nuijens, J.H. 2001. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infecti. Immun. 69(3): 1469-1476.
146. Nilsson, E., Kollberg, H., Johannesson, M., Wejaker, P.E., Carlander, D., and Larsson, A. 2007. More than 10 years’ continuous oral treatment with specific immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: A case report. J. Med. Food 10(2): 375-378.
147. Nilsson, E., Larsson, A., Olesen, H.V., Wejaker, P.E., and Kollberg, H. 2008. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatr. Pulmonol. 43(9): 892-899.
148. Nomura, S., Suzuki, H., Masaoka, T., Kurabayashi, K., Ishii, H., Kitajima, M., Nomoto, K., and Hibi, T. 2005. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in mongolian gerbils. Helicobacter 10(1): 43-52.
149. Numan, S.C., Veldkamp, P., Kuijper, E.J., van den Berg, R.J., and van Dissel, J.T., 2007. Clostridium difficile-associated diarrhoea: Bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut 56(6): 888-889.
150. Ochoa, T.J., Chea-Woo, E., Campos, M., Pecho, I., Prada, A., McMahon, R.J. et al. 2008. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clini. Infect. Diseases 46(12): 1881-1883.
151. Ochoa, T.J. and Cleary, T.G. 2004. Lactoferrin disruption of bacterial type III secretion systems. Biometals 17(3): 257-260.
152. Ochoa, T.J. and Cleary T.G. 2009. Effect of lactoferrin on enteric pathogens. Biochimie 91: 30-34.
153. Ochoa, T.J., Noguera-Obenza, M., Ebel, F., Guzman, C.A., Gomez, H.F., and Cleary, T.G. 2003. Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect. Immun. 71(9): 5149-5155.
154. Oevermann, A., Engels, M., Thomas, U., and Pellegrini, A. 2003. The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification. Antiviral Res. 59: 23-33.
155. Oona, M., Rägo, T., Maaroos, H.I., Mikelsaar, M., Lõivukene, K., Salminen, S., and Korhonen, H. 1997. Helicobacter pylori in children with abdominal complaints: Has immune bovine colostrum some influence on gastritis? Alpe Adria Microbiol. J. 6: 49-57.
156. Pacyna, J., Siwek, K., Terry, S.J., Roberton, E.S., Johnson, R.B., and Davidson, G.P. 2001. Survival of rotavirus antibody activity derived from bovine colostrum after passage through the human gastrointestinal tract. J. Pediatr. Gastroenter. Nutr. 32: 162-167.
157. Pan, Y., Rowney, M., Guo, P., and Hobman, P. 2007a. Biological properties of lactoferrin: An overview. Austral. J. Dairy Technol. 62: 31-42.
158. Pan, Y., Wan, J., Roginski, H., Lee, A., Shiell, B., Michalski, W.P. et al. 2007b. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral prop­erties of lactoferrin. Lett. Applied Microbiol. 44(3): 229-234.
159. Pant, N., Marcotte, H., Brussow, H., Svensson, L., and Hammarström, L. 2007. Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol. 7(1): 86.
160. Pellegrini, A. 2003. Antimicrobial peptides from food proteins. Curr. Pharmaceut. Des. 9: 1225-1238.
161. Pellegrini, A., Dettling, C., Thomas, U., and Hunziker, P. 2001. Isolation and characterization of four bactericidal domains in the bovine β-lactoglobulin. Biochimica et Biophysica Acta 1526: 131-140.
162. Pellegrini, A., Hülsmeier, A.J., Hunziker, P., and Thomas, U. 2004. Proteolytic frag­ments of ovalbumin display antimicrobial activity. Biochimica et Biophysica Acta 1672(2): 76-85.
163. Pellegrini, A., Thomas, U., Bramaz, N., Hunziker, P., and von Fellenberg, R. 1999. Isolation and identification of three bactericidal domains in the bovine alpha-lactalbumin molecule. Biochimica et Biophysica Acta 1426: 439-448.
164. Pellegrini, A., Thomas, U., Wild, P., Schraner, E., and von Fellenberg, R. 2000. Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli. Microbiol. Res. 155(2): 69-77.
165. Petitclerc, D., Lauzon, K., Cochu, A., Ster, C., Diarra, M.S., and Lacasse, P. 2007. Efficacy of a lactoferrin-penicillin combination to treat {beta}-lactam-resistant Staphylococcus aureus mastitis. J. Dairy Sci. 90(6): 2778-2787.
166. Petschow, B.W. and Talbott, R.D. 1994. Reduction in virus-neutralizing activity of a bovine colostrum immunoglobulin concentrate by gastric acid and digestive enzymes. J. Pediatr. Gastroent. Nutr. 19(2): 228-235.
167. Phelan, M., Aherne, A., Fitzgerald, R.J., and O’Brien, N.M. 2009. Casein-derived bio­active peptides: Biological effects, industrial uses, safety aspects and regulatory status. Int. Dairy J. 19(11): 643-654.
168. Pihlanto, A. and Korhonen, H. 2003. Bioactive peptides and proteins. In Advances in Food and Nutrition Research (S.L. Taylor, Ed.), San Diego: Elsevier, pp. 175-276.
169. Pihlanto-Leppälä, A., Marnila, P., Hubert, L., Rokka, T., Korhonen, H.J.T., and Karp, M. 1999. The effect of α-lactalbumin and β-lactoglobulin hydrolysates on the metabolic activity of Escherichia coli JM103. J. Appl. Microbiol. 87: 540-545.
170. Plaut, A.G., Qiu, J., and St Geme, J.W. 2000. Human lactoferrin proteolytic activity: Analysis of the cleaved region in the IgA protease of Haemophilus influenzae. Vaccine 19(Suppl 1): S148-S152.
171. Pouliot, Y., Gauthier, S.F., and Groleau, P.E. 2006. Membrane-based fractionation and purification strategies for bioactive peptides. In Nutraceutical Proteins and Peptides in Health and Disease (Y. Mine and F. Shahidi, Eds.), Boca Raton, FL: Taylor & Francis, pp. 639-658.
172. Powers, J.-P.S. and Hancock, R.E.W. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24: 1681-1691.
173. Rautemaa, R. and Meri, S. 1999. Complement-resistance mechanisms of bacteria. Microbes Infect 1(10): 785-794.
174. Recio, I. and Visser, S. 1999. Identification of two distinct antibacterial domains within the sequence of bovine αs2-casein. Biochimica et Biophysica Acta 1428:314-326.
175. Reilly, R.M., Domingo, R., and Sandhu, J. 1997. Oral delivery of antibodies. Future pharmacokinetic trends. Clin. Pharmacokinet. 32(4): 313-323.
176. Reiter, B. and Brock, J.H. 1975. Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. I. complement-mediated bactericidal activity of antibodies to a serum susceptible strain of E. coli of the serotype O 111. Immunology 28(1): 71-82.
177. Reiter, B. and Oram J.D. 1967. Bacterial inhibitors in milk and other biological fluids. Nature 216: 28-30.
178. Reiter, B. and Perraudin, J-P. 1991. Lactoperoxidase: Biological functions. In Peroxidases in Chemistry and Biology (J. Everse, K.E. Everse, and M.B. Grisham, Eds.), Boca Raton, FL: CRC Press, pp. 143-180.
179. Rhoades, J.R., Gibson, G.R., Formentin, K., Beer, M., Greenberg, N., and Rastall, R.A. 2005. Caseinoglycomacropeptide inhibits adhesion of pathogenic Escherichia coli strains to human cells in culture. J. Dairy Sc. 88(10): 3455-3459.
180. Richardson, A., de Antueno, R., Duncan, R., and Hoskin, D.W. 2009. Intracellular delivery of bovine lactoferricin’s antimicrobial core (RRWQWR) kills T-leukemia cells. Biochem. Biophys. Res. Commun. 388: 736-741.
181. Rizzello, C.G., Losito, I., Gobbetti, M., Carbonara, T., De Bari, M.D., and Zambonin, P.G. 2005. Antibacterial activities of peptides from the water-soluble extracts of Italian cheese varieties. J. Dairy Sci. 88: 2348-2360.
182. Roberts, A.K., Chierici, R., Sawatzki, G., Hill, M.J., Volpato, S., and Vigi, V. 1992. Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paediatrica 81(2): 119-124.
183. Roos, N., Mahe, S., Benamouzig, R., Sick, H., Rautureau, J., and Tome, D. 1995. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J. Nutr. 125(5): 1238-1244.
184. Rydlo, T., Miltz, J., and Mor, A. 2006. Eukaryotic antimicrobial peptides: Promises and premises in food safety. J. Food Sci. 71: R125-R135.
185. Samuelsen, Ø., Haukland, H.H., Jenssen, H., Krämer, M., Sandvik, K., Ulvatne, H. et al. 2005. Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. FEBS Lett. 579(16): 3421-3426.
186. Sarker, S.A., Casswall, T.H., Juneja, L.R., Hoq, E., Hossain, I., Fuchs, G.J., and Hammarström, L. 2001. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J. Pediatr. Gastroent. Nutr. 32(1): 19-25.
187. Sarker, S.A., Casswall, T.H., Mahalanabis, D., Alam, N.H., Albert, M.J., Brüssow, H., Fuchs, G.J., and Hammerström, L. 1998. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr. Infect. Disease J. 17(12): 1149-1154.
188. Sava, G. 1996. Pharmacological aspects and therapeutic applications of lysozymes. EXS 75: 433-449.
189. Sava, G., Pacor, S., Dasig, G., and Bergamo, A. 1995. Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas. Anticancer Res. 15: 1883-1888.
190. Scammell, A.W. 2001. Production and uses of colostrum. Austral. J. Dairy Technol. 56(2): 74-82.
191. Schade, R., Calzado, E.G., Sarmiento, R., Chacana, P.A., Porankiewicz-Asplund, J., and Terzolo, H.R. 2005. Chicken egg yolk antibodies (IgY-technology): A review of progress in production and use in research and human and veterinary medi­cine. Alternatives to Laboratory Animals: ATLA 33(2): 129-154.
192. Seifu, E., Buys, E.M., and Donkin, E.F. 2005. Significance of the lactoperoxidase system in the dairy industry and its potential applications: A review. Trends Food Sci. Technol. 16: 137-154.
193. Shimazaki, Y., Mitoma, M., Oho, T., Nakano, Y., Yamashita, Y., Okano, K., Nakano, Y. et al. 2001. Passive immunization with milk produced from an immunized cow prevents oral recolonization by streptococcus mutans. Clin. Vaccine Immunol. 8(6): 1136-1139.
194. Shin, J.H., Yang, M., Nam, S.W., Kim, J.T., Myung, N.H., Bang, W.G., and Roe, I.H. 2002. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin. Diagnostic Lab. Immunol. 9(5; Sep): 1061-1066.
195. Shin, K., Wakabayashi, H., Yamauchi, K., Teraguchi, S., Tamura, Y., Kurokawa, M., and Shiraki, K. 2005. Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice. J. Med. Microbiol. 54: 717-723.
196. Singh, K., Parsek, M.R., Greenberg, E.P., and Welsh M.J. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417(6888): 552-555.
197. Smith, D.J., King, W.F., and Godiska, R. 2001. Passive transfer of immunoglobulin Y antibody to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries. Infect. Immun. 69(5): 3135-3142.
198. Suzuki, H., Nomura, S., Masaoka, T., Goshima, H., Kamata, N., Kodama, Y., Ishii, H., Kitajima, M., Nomoto, K., and Hibi, T. 2004. Effect of dietary anti-helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Aliment. Pharmacol. Therapeut. 20 (Suppl 1): 185-192.
199. Tacket, C.O., Losonsky, G., Link, H., Hoang, Y., Guesry, P., Hilpert, H., and Levine, M.M. 1988. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic escherichia coli. New Engl. J. Med. 318(19): 1240-1243.
200. Tamano, S., Sekine, K., Takase, M., Yamauchi, K., Iigo, M., and Tsuda, H. 2008. Lack of chronic oral toxicity of chemopreventive bovine lactoferrin in F344/DuCrj rats. Asian Pacific J.Cancer Prevent. 9(2): 313-316.
201. Tawfeek, H.I., Najim, N.H., and Al-Mashikhi, S. 2003. Efficacy of an infant formula containing anti-escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: A field trial. Int. J. Infect. Diseases 7(2): 120-128.
202. Taylor, S., Brock, J., Kruger, C., Berner, T., and Murphy, M. 2004. Safety determination for the use of bovine milk-derived lactoferrin as a component of an antimicro­bial beef carcass spray. Reg. Toxicol. Pharmacol. 39(1): 12-24.
203. Tenovuo, J. 2002. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: Efficacy and safety. Oral Diseases 8: 23-29.
204. Tenovuo J., Lumikari, M., and Soukka, T. 1991. Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive denstistry. Proc. Finnish Dentist. Soc. 87: 197-208.
205. Thammasirirak, S., Pukcothanung, Y., Preecharram, S., Daduang, S., Patramanon, R., Fukamizo, T. et al. 2010. Antimicrobial peptides derived from goose egg white lysozyme. Compar. Biochem. Physiol. Part C: Toxicol. Pharmacol. 151(1): 84-91.
206. Thomä-Worringer, C., Sörensen, J., and López-Fandino, R. 2006. Health effects and technological features of caseinomacropeptide. Int. Dairy J. 16: 1324-1333.
207. Thurman, J.M. and Holers, V.M. 2006. The central role of the alternative complement pathway in human disease. J. Immunol. 176(3): 1305-1310.
208. Tomita, M., Wakabayashi, H., Shin, K., Yamauchi, K., Yaeshima, T., and Iwatsuki, K. 2009. Twenty-five years of research on bovine lactoferrin appications. Biochimie 91: 52-57.
209. Tomita, M., Wakabayashi, H., Yamauchi, K., Teraguchi, S., and Hayasawa, H. 2002. Bovine lactoferrin and lactoferricin derived from milk: Production and applications. Biochem. Cell Biol. 80(1): 109-112.
210. Tripathi, V. and Vashishtha, B. 2006. Bioactive compounds of colostrum and its application. Food Rev. Int. 22: 225-244.
211. Tsuge, Y., Shimoyamada, M., and Watanabe, K. 1996. Differences in hemagglutination inhibition activity against bovine rotavirus and hen newcastle disease virus based on the subunits in hen egg white ovomucin. Biosci. Biotechnol. Biochem. 60(9): 1505-1506.
212. Tsuge, Y., Shimoyamada, M., and Watanabe, K. 1997. Structural features of Newcastle Disease virus-and anti-ovomucin antibody-binding glycopeptides from pronase-treated ovomucin. J. Agric. Food Chem. 45(7): 2393-2398.
213. Tsuji, S., Hirata, Y., and Matsuoka, K. 1989. Two apparent molecular forms of bovine lactoferrin. J. Dairy Sci. 72(5): 1130-1136.
214. Ueta, E., Tanida, T., and Osaki, T.2001. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J. Peptide Res. 57(3): 240-249.
215. Ulvatne, H., Haukland, H.H., Olsvik, O., and Vorland, L.H. 2001. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett. 492(1-2): 62-65.
216. Ulvatne, H., Haukland, H.H., Samuelsen, Ø., Krämer, M., and Vorland, L.H. 2002. Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. J. Antimicrob. Chemother. 50(4): 461-467.
217. Ulvatne, H., Samuelsen, Ø., Haukland, H.H., Krämer, M., and Vorland, L.H. 2004. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol. Lett. 237(2): 377-384.
218. Valenti, P. and Antonini, G. 2005. Lactoferrin: An important host defence against microbial and viral attack. Cell. Molec. Life Sci. 62(22): 2576-2587.
219. Valenti, P., Greco, R., Pitari, G., Rossi, P., Ajello, M., Melino G. et al. 1999. Apoptosis of Caco-2 intestinal cells invaded by Listeria monocytogenes: protective effect of lactoferrin. Exper. Cell Res. 250(1): 197-202.
220. van der Kraan, M.I.A., Groenink, J., Nazmi, K., Veerman, E.C.I., Bolscher, J.G.M., and Nieuw Amerongen, A.V. 2004. Lactoferrampin: A novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25: 177-183.
221. van Dissel, J.T., de Groot, N., Hensgens, C.M.H., Numan, S., Kuijper, E.J., Veldkamp, P. et al. 2005. Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: Preclinical and preliminary clini­cal data. J. Med. Microbiol. 54(2): 197-205.
222. van Hooijdonk, A.C.M., Kussendrager, K.D., and Steijns, J.M. 2000. In vivo antimicroibial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Brit. J. Nutr. 84 (Suppl 1): S127-S134.
223. Venkatesh, M.P. and Rong, L. 2008. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis. J. Med. Microbiol. 57: 1113-1121.
224. Vercruysse, L., Van Camp, J., Dewettinck, K., and Smagghe, G. 2009. Production and enrichment of bioactive peptides derived from milk proteins. In Dairy-Derived Ingredients: Food and Nutraceutical Uses (M. Corredig, Ed.), Oxford, UK: Woodhead, pp. 51-67.
225. Viejo-Díaz, M., Andrés, M.T., and Fierro, J.F. 2004. Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob. Agents Chemother. 48(4): 1242-1248.
226. Vorland, L.H. 1999. Lactoferrin: A multifunctional glycoprotein. Review article. APMIS 107: 971-981.
227. Wakabayashi, H., Kondo, I., Kobayashi, T., Yamauchi, K., Toida, T., Iwatsuki, K., and Yoshie, H. 2010. Periodontitis, periodontopathic bacteria and lactoferrin. Biometals 23: 419-424.
228. Wakabayashi, H., Takase, M., and Tomita, M. 2003. Lactoferricin derived from milk protein lactoferrin. Curr. Pharmaceut. Des. 9(16): 1277-1287.
229. Wakabayashi, H., Yamauchi, K., and Takase, M. 2006. Lactoferrin research, technology and applications. Int. Dairy J. 16: 1241-1251.
230. Warny, M., Fatimi, A., Bostwick, E.F., Laine, D.C., Lebel, F., LaMont, J.T., Pothoulakis, C., and Kelly C.P. 1999. Bovine immunoglobulin concentrate-clostridium difficile retains C. difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut 44(2): 212-217.
231. Wei, H., Loimaranta, V., Tenovuo, J., Rokka, S., Syväoja, E.L., Korhonen, H. et al. 2002. Stability and activity of specific antibodies against Streptococcus mutans and Streptococcus sobrinus in bovine milk fermented with Lactobacillus rhamnosus strain GG or treated at ultra-high temperature. Oral Microbiol. Immunol. 17(1): 9-15.
232. Weinberg, E.D. 2003. The therapeutic potential of lactoferrin. Expert Opin. Investig. Drugs 12(5): 841-851.
233. Weinberg, E.D. 2007. Antibiotic properties and applications of lactoferrin. Curr. Pharmaceut. Des. 13(8): 801-811.
234. Weiner, C., Pan, Q., Hurtig, M., Boren, T., Bostwick, E., and Hammarström, L. 1999. Passive immunity against human pathogens using bovine antibodies. Clin. Exper. Immunol. 116: 193-205.
235. Worledge, K.L., Godiska, R., Barrett, T.A., and Kink, J.A., 2000. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats. Digest. Diseases Sci. 45(12): 2298-2305.
236. Xu, L.B., Chen, L., Gao, W., and Du, K.H. 2006. Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG. Vaccine 24(12): 2131-2140.
237. Yamauchi, K., Hiruma, M., Yamazaki, N., Wakabayashi, H., Kuwata, H., Teraguchi, S. et al. 2000a. Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study. Mycoses 43(5): 197-202.
238. Yamauchi, K., Toida, T., Nishimura, S., Nagano, E., Kusuoka, O., Teraguchi S. et al. 2000b. 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem. Toxicol. 38(6): 503-512.
239. Yolken, R.H., Leister, F., Wee, S.B., Miskuff, R., and Vonderfecht, S. 1988. Antibodies to rotaviruses in chickens‘ eggs: A potential source of antiviral immunoglobulins suitable for human consumption. Pediatrics 81(2): 291-295.
240. Young, K.W.H., Munro, I.C., Taylor, S.L., Veldkamp, P., and van Dissel, J.T. 2007. The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile. Regulatory Toxicol. Pharmacol. 47(3): 317-326.
241. Zucht, H.-D., Raida, M., Adermann, K., Magert, H.J., and Forssmann, W.G. 1995. Casocidin-I: A casein-αs2 derived peptide exhibits antibacterial activity. FEBS Lett. 372: 185-188.